Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Muscular Dystrophy Treatment
Bayer: Transforming Healthcare through Collaborations and Breakthrough Innovation – Taiwan Business TOPICS – Taiwan Business TOPICS
Posted: Published on February 2nd, 2021
Finding effective solutions to the worlds health issues requires novel, holistic approaches and collaborative ingenuity. Healthcare companies must therefore increasingly shift their focus to the research and development of medical technologies, biopharmaceuticals, and innovative therapies to treat conditions and diseases that are difficult or nearly impossible to tackle using traditional medicines. Such a reality is well understood by Bayer AG Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Bayer: Transforming Healthcare through Collaborations and Breakthrough Innovation – Taiwan Business TOPICS – Taiwan Business TOPICS
Orchard Therapeutics Appoints Braden Parker as Chief Commercial OfficerCommercial Launch of Libmeldy in Europe On-Track for 1H 2021 – BioSpace
Posted: Published on February 2nd, 2021
BOSTONandLONDON, Jan. 29, 2021 (GLOBE NEWSWIRE) --Orchard Therapeutics(Nasdaq: ORTX), a global gene therapy leader, today announced the appointment of Braden Parker to the role of Chief Commercial Officer (CCO). In this capacity, Mr. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Orchard Therapeutics Appoints Braden Parker as Chief Commercial OfficerCommercial Launch of Libmeldy in Europe On-Track for 1H 2021 – BioSpace
Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology – PRNewswire
Posted: Published on January 24th, 2021
HACKENSACK, N.J., Jan. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology – PRNewswire
Muscular Dystrophy Treatment Market Trends, Drivers, Strategies, Applications and Competitive Landscape Till 2026 | Santhera Pharmaceuticals, PTC…
Posted: Published on January 24th, 2021
The Global Muscular Dystrophy Treatment Market report provides a holistic evaluation of the market for the forecast period (20192025). The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics involve the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Muscular Dystrophy Treatment Market Trends, Drivers, Strategies, Applications and Competitive Landscape Till 2026 | Santhera Pharmaceuticals, PTC…
Dr. Artero’s Lab Researching on microRNA-based treatments for Myotonic Dystrophy Type 1 by Translational Genomics Group – PRNewswire
Posted: Published on January 24th, 2021
About Myotonic Dystrophy Type 1 Myotonic dystrophy type 1 (DM1) is a life-threatening and chronically debilitating disease. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Dr. Artero’s Lab Researching on microRNA-based treatments for Myotonic Dystrophy Type 1 by Translational Genomics Group – PRNewswire
HC asks medical team to submit report on siblings with muscular dystrophy – The Hindu
Posted: Published on January 24th, 2021
The Delhi High Court on Monday directed the city government to constitute a medical team to check on a sister and brother siblings suffering from muscular dystrophy within five days. Justice Pratibha M. Singh asked the medical team to submit a report on the conditions of the siblings before the next date of hearing on January 28 Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on HC asks medical team to submit report on siblings with muscular dystrophy – The Hindu
Seelos Therapeutics Receives a Notice of Allowance in Japan for SLS-005 (Trehalose) – PRNewswire
Posted: Published on January 24th, 2021
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has received a Notice of Allowance from the Japanese Patent Office (Japanese patent number 2016-512480) covering SLS-005 titled: "Treatment of Protein Aggregation Myopathic and Neurodegenerative Diseases by Parenteral Administration of Trehalose". Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Seelos Therapeutics Receives a Notice of Allowance in Japan for SLS-005 (Trehalose) – PRNewswire
Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes – GlobeNewswire
Posted: Published on January 24th, 2021
January 19, 2021 09:15 ET | Source: Capricor Therapeutics -Enhanced Signaling Pathways Show Increased Potency Through Expression of MicroRNAs- -Publication Further Supports Capricors Exosome Platform Advancement- LOS ANGELES, Jan. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes – GlobeNewswire
Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares -…
Posted: Published on January 24th, 2021
CAMBRIDGE,Mass., Jan. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares -…
FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2 -…
Posted: Published on December 28th, 2020
December 22, 2020 07:00 ET | Source: FibroGen, Inc SAN FRANCISCO, Dec. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2 -…